Novo Nordisk A S (NONOF) balance sheet

NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO

Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30

$38.24−0.60 (-1.53%)

Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –

Novo Nordisk A S balance sheet

Annual Quarterly

DKK USD

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Cash & Equivalents	4,158	2,173	2,136	1,820	1,631	2,010	2,316	2,398	2,770	2,620	2,306	2,223
Cash & Short-Term Investments	4,158	2,173	2,136	1,820	1,631	2,010	2,316	2,398	2,770	2,620	2,306	2,223
Receivables	11,134	9,987	9,612	7,273	6,186	4,559	3,743	3,496	3,256	2,872	–	–
Inventory	7,797	5,670	4,721	3,508	2,986	3,047	2,651	2,507	2,482	2,035	–	–
Total Current Assets	27,098	22,456	20,723	15,564	13,027	10,817	9,384	9,063	9,701	8,482	–	–
Property, Plant & Equipment	–	–	13,498	9,591	8,426	8,263	7,595	6,428	5,691	4,283	–	–
Operating Lease Right-of-Use Assets	1,333	950	879	594	584	556	531	580	–	–	–	–
Goodwill	3,118	2,778	–	–	–	–	–	–	–	–	–	–
Intangible Assets	17,317	12,604	8,964	7,328	6,571	3,395	877	789	537	385	–	–
Deferred Tax Assets	3,716	3,421	3,024	2,000	1,320	964	619	444	313	381	–	–
Total Assets	85,308	64,630	46,668	34,706	29,604	23,821	18,874	16,997	16,527	13,843	13,358	–
Short-Term Debt	1,888	1,820	961	211	2,083	1,226	221	79	274	32	–	–
Current Portion of Long-Term Debt	1,888	1,820	961	211	2,083	1,226	221	79	–	–	–	–
Current Debt	3,777	3,640	1,923	422	4,165	2,452	443	158	274	32	–	–
Current Portion of Leases	210	186	174	142	125	127	122	–	–	–	–	–
Current Income Taxes Payable	1,322	1,349	1,056	1,020	557	643	633	707	685	564	–	–
Other Current Liabilities	6,242	4,910	4,260	3,396	2,983	2,795	2,267	2,163	2,333	2,013	–	–
Total Current Liabilities	33,888	30,205	25,176	17,398	15,146	11,551	8,862	8,311	7,598	6,732	–	–
Long-Term Debt	18,690	12,447	3,046	3,498	1,973	476	452	0	–	–	–	–
Long-Term Leases	1,137	753	675	510	503	476	452	–	–	–	–	–
Operating Lease Liabilities	1,347	939	850	652	628	604	575	–	–	–	–	–
Deferred Tax Liabilities	1,039	765	1,508	1,016	802	411	12	18	137	1.84	–	–
Other Long-Term Liabilities	–	3.19	28	14	55	0	–	–	–	–	–	–
Total Liabilities	54,817	44,714	30,855	22,696	18,836	13,412	10,220	9,042	8,483	7,418	–	–
Total Debt	22,466	16,087	4,969	3,920	6,138	2,928	895	158	274	32	–	–
Common Stock	70	62	67	66	70	77	72	75	81	72	–	–
Retained Earnings	30,688	20,049	15,558	11,593	10,959	10,482	8,687	8,195	7,908	6,544	–	–
Treasury Stock	-0.31	-0.28	-0.74	-0.86	-0.91	-1.31	-1.50	-1.69	-1.78	-1.28	–	–
Total Equity	30,491	19,916	15,813	12,010	10,767	10,409	8,654	7,954	8,043	6,425	6,835	6,548
Total Liabilities & Equity	85,308	64,630	46,668	34,706	29,604	23,821	18,874	16,997	16,527	13,843	–	–
Shares Outstanding(shares)	4,444	4,441	4,458	4,500	4,620	4,700	4,800	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 81.0%
Operating margin: 41.3%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 0.80
Debt to equity: –
Debt to assets: 26.3%
Cash to current liabilities: 12.3%

Valuation

P/E ratio: 11.1
Price to sales: 3.70
Price to book: –
Dividend yield: –

See a number that looks wrong?